Department of Obstetrics, Gynecology and Reproductive Science, Division of Maternal Fetal Medicine, Columbia University Irving Medical Center, New York, NY USA.
Department of Obstetrics, Gynecology and Reproductive Science, Division of Maternal Fetal Medicine, Columbia University Irving Medical Center, New York, NY USA.
Semin Perinatol. 2020 Nov;44(7):151287. doi: 10.1016/j.semperi.2020.151287. Epub 2020 Jul 21.
The highly contagious severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has affected every aspect of medical practice and has all but ceased clinical, translational and basic science research. Pregnant women appear to be similarly affected by the virus as non-pregnant adults. As obstetricians, not only do we have a duty to care for pregnant women and their fetuses, but to continue to conduct research, inclusive of that which would guide us in delivering care during a pandemic. Conducting such research has its challenges. The objective of this chapter is to review the impact of SARS-CoV-2 on ongoing and new pregnancy research during the pandemic, describe the challenges encountered and summarize the key strategies necessary for a successful research environment.
高传染性的严重急性呼吸综合征冠状病毒 2（SARS-CoV-2）已经影响到医学实践的各个方面，几乎停止了临床、转化和基础科学研究。孕妇似乎与未怀孕的成年人一样受到该病毒的影响。作为妇产科医生，我们不仅有责任照顾孕妇及其胎儿，而且还要继续进行研究，包括那些指导我们在大流行期间提供护理的研究。开展此类研究具有一定的挑战性。本章的目的是回顾大流行期间 SARS-CoV-2 对正在进行和新的妊娠研究的影响，描述所遇到的挑战，并总结成功的研究环境所需的关键策略。
